FDA
Sorafenib Tosylate
The FDA lists this product in 6 strengths and forms.
Composition
- Active ingredients
- SORAFENIB TOSYLATE EQ 200MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- SORAFENIB TOSYLATE EQ 200MG BASE · TabletANDA209567-001 · Prescription
- SORAFENIB TOSYLATE EQ 200MG BASE · TabletANDA207012-001 · Prescription
- SORAFENIB TOSYLATE EQ 200MG BASE · TabletANDA216073-001 · Prescription
- SORAFENIB TOSYLATE EQ 200MG BASE · TabletANDA209050-001 · Prescription
- SORAFENIB TOSYLATE EQ 200MG BASE · TabletThis page
- SORAFENIB TOSYLATE EQ 200MG BASE · TabletANDA217095-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA212228.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Sorafenib Tosylate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Apotex
- Status
- Discontinued
- FDA approval
- 27 Jan 2025
- Application
- ANDA212228-001



